Everand Logo

Welcome to Everand!

  • MoneyWeek

    MoneyWeek’s comprehensive guide to this week’s share tips

    Jun 28, 2024 3 minutes

    Five to buy

    GSK

    GSK’s market value has fallen sharply recently owing to legal battles over its heartburn drug Zantac, which has been hit by fears that it increases the risk of cancer. The pharmaceutical giant has also faced criticism for its handling of mergers and Covid-vaccine development. However, GSK has been steadily improving its drug pipeline, increasing research and development (R&D) spending, “fattening up” its margins, and has a “chunky dividend yield to

    You’re reading a preview, subscribe to read more.

    More from MoneyWeek

    MoneyWeek3 min read
    Best Of The Financial Columnists
    Donald Trump’s plan to “rid the nation” of an estimated 11 to 14 million undocumented immigrants would cost a minimum of $315bn and “subtract more than 4%” from GDP, according to an American Immigration Council (AIC) report last week. Yet the prospec
    MoneyWeek2 min read
    A Short-term Kick For China
    It’s often claimed that China’s leaders take a long view, unlike the short-term thinking that prevails in Western economies. Looking at the markets, we might doubt how well that’s working. Late last month, the government abruptly unveiled a series of
    MoneyWeek2 min read
    Book In The News… Fascinating Insights Into A Turbulent Time For Britain
    Secrets, Lies and the Truth about Five Prime Ministers Graham Brady Ithaka, £25 The Conservative Party likes to think of itself as the “natural party of government”, but in less than a quarter of a century, it has had no fewer than eight leaders (Wi

    Related Books & Audiobooks